Can members of Congress buy stocks and other investment products while in office? Yes — federal law allows it, but the STOCK Act requires lawmakers to publicly disclose those trades within a set window. The latest filing to surface on that front comes from Hon. Jefferson Shreve, a member of the U.S. House of Representatives, who reported a new purchase dated February 17, 2026.
According to the Periodic Transaction Report filed with the House, Shreve personally purchased an asset listed as ‘Prudential RILA – 10% Buffer 3-year Alliance Bernstein 500 Plus Index [VA].’ The transaction was disclosed in the $1,000,001 to $5,000,000 range, one of the broader bands used on these forms to capture larger purchases without pinpointing an exact dollar figure.
What Kind of Asset Is This?
Unlike a typical equity or ETF trade, this filing involves a Registered Index Linked Annuity, or RILA — an insurance-based product rather than a stock purchase in the traditional sense. RILAs let buyers participate in the performance of a market index, in this case the Alliance Bernstein 500 Plus Index, while including a 10% buffer designed to absorb a portion of losses over a set three-year term. Shreve’s own description of the transaction, entered on the disclosure form, characterizes it as a ‘Buffered Indexed Annuity Exchange,’ suggesting the purchase may have involved exchanging one annuity contract for another rather than a fresh cash outlay.
The filing lists the holding as being maintained directly through the Registered Index Linked Annuity structure, distinct from a standard brokerage account. That distinction matters for readers trying to compare this disclosure to more familiar congressional stock trades, such as the kind that regularly show up in coverage of Nancy Pelosi’s portfolio performance or holdings. Annuity products like this one behave differently from individual stocks, with returns tied to an index formula and capped or buffered rather than fully exposed to market swings.
Why This Shows Up in Disclosure Trackers
Our system classifies this filing as a ‘congress buy’ signal, reflecting that it represents a reported purchase transaction rather than a sale. The STOCK Act requires this kind of disclosure regardless of whether the underlying asset is a stock, bond, fund, or insurance product like a RILA — the law is about transparency, not a judgment on the investment itself. Nothing in the filing indicates any impropriety, and the report is a routine compliance document rather than an allegation of wrongdoing.
Readers tracking congressional financial disclosures can expect to see a mix of asset types in these filings, from common stock trades to less conventional products like buffered annuities. This particular report offers a look at how one member of Congress is structuring a portion of personal holdings through an insurance-linked vehicle tied to market index performance.